Lead sponsor
Rottapharm Spain
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
39
Total enrollment
0
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2/3
1
Trials by status
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia PatientsPrimary or mixed dementiaPh 2/3Terminated39